ProText Mobility Inc (TXTM)

[Trademanager]

The subsidiary of TXTM is Plandai responds nicely to
the News shifting from Purely a biotechnology research
and development company to a company that's more focused
on operations and sales. ProText Mobility undervalued?

New investors who see the value of the products,
the exclusive worldwide license,
the full medicinal potential of cannabis extract
and the combinatie between Plandai Biotechnology
(plpl) and Protext Mobility for more
focus from operations to sales.